Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Pain 9Cancer Pain 5Head and Neck Neoplasms 3Colonic Neoplasms 3Agnosia 3Rectal Neoplasms 2Chronic Pain 2Breakthrough Pain 2post laminectomy syndrome 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Terminal Cancer 1Prostatic Neoplasms 1Postoperative Cognitive Complications 1Polyps 1Pleural Effusion, Malignant 1Patient Satisfaction 1Pain, Postoperative 1Neoplasms 1Nasopharyngeal Carcinoma 1Lymphoma, Follicular 1Lung Neoplasms 1Kidney Neoplasms 1Ileus 1Failed Back Surgery Syndrome 1Emergencies 1Diverticulosis, Colonic 1Diverticulitis, Colonic 1Constipation 1Arrhythmias, Cardiac 1

Interventions

Ketamine 2Diclofenac 2Acetaminophen 2Surveys and Questionnaires 1Psychotherapy 1Passive Cutaneous Anaphylaxis 1Oxycodone 1Gabapentin 1Fentanyl 1Anesthesia, General 1Analgesia, Patient-Controlled 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Acute Pain × Fentanyl × Clear all
NCT03959852 2020-09-11

Sub-Dissociative Ketamine and Fentanyl to Treat Moderate to Severe Pain

Mercy Health Ohio

Phase 4 Terminated
6 enrolled
Lymphoid

Lymphoma, Follicular, Pain, Acute Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡